RE: OPTI11 May 2020 09:03
Steve Wu, General Manager at MAXCARE Inc, commented: "The weight management market constitutes circa USD$2 billion value in Taiwan each year (Source: Functional Food Status Report 2018). Besides the traditional sales channels, an increasing number of weight loss clinics has also greatly driven its growth. There are abundant products that target weight loss on the market, yet very few have scientifically and clinically proven efficacies, with no side effects. SlimBiome® of OptiBiotix is a patented product, with clinical proof to improve gut microbiome, support weight lost, stabilise blood sugar and reduce cravings for food, which all lead to successful weight management. It has always been our goal to partner with companies that are capable of producing such products. MAXCARE represents a large number f nutraceutical ingredients with clinical studies, manufactured by pharmaceutical and/or major food manufacturers, and it is our great pleasure to be working with Optibiotix for the distribution of SlimBiome® in Taiwan. We are very optimistic about the prospects of SlimBiome® in this region and look forward to working with the OptiBiotix team to maximise the potential."